Advanced functional nanomaterials for precise cancer diagnosis - nanoCANdi

Project summary

NanoCANdi develops new functional materials and biosensing microtechnology for cancer diagnosis. The project designs and manufactures large magnetic moment nanostructures with unique spin configurations for biomedical applications, specifically optimized for ultra-high sensitive giant magnetoresistance biosensors by micromagnetic modelling of both nanostructures and sensors. It addresses a key strategy in the fight against cancer: the early-stage detection of the disease. A crucial feature in this strategy is the specific biorecognition of cancer indicators. NanoCANdi undertakes this key point creating exclusive aptamers for a precise immobilization of cancer biomarkers, developing an innovative aptakiss/aptaswitch selection approach. The project expands new technologies and materials, producing biosensing devices that will impact the healthcare system with the adoption of precise medicine, letting physicians to detect and monitor treatments with reliable and affordable biochips.

Project Details

Call

Call 2022


Call Topic

Functional materials


Project start

01.10.2023


Project end

30.09.2026


Total project costs

872.172 €


Total project funding

685.922 €


TRL

2 - 5


Coordinator

Prof. Rafael Morales

UPV/EHU, BARRIO SARRIENA S N, 48940 LEIOA, Spain


Partners and Funders Details

Consortium Partner   Country Funder
UPV/EHU
https://www.ehu.eus
University Spain ES-AEI
IMG Pharma
https://www.imgpharma.com
SME Spain ES-EJ-GV/Innobasque
INSERM
https://arna.cnrs.fr/
Research org. France FR-ANR
CSIC
https://www.csic.es
Research org. Spain ES-AEI
UNICAMP
https://www.unicamp.br
University Brazil BR-FAPESP

Keywords

advanced functional materials, biosensor, diagnostic device, magnetic materials, magnetic sensor, nanomagnetism